CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)
CV Sciences (CVSI) reported Non-Current Deffered Revenue of $1.5 million for Q4 2020, up 9.33% sequentially from $1.3 million in Q4 2018.
CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020) Analysis & Trends
CV Sciences (CVSI) has 3 years of Non-Current Deffered Revenue data on file, last reported at $1.5 million in Q4 2020.
- For the quarter ending Q4 2020, Non-Current Deffered Revenue changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2020 stood at $1.5 million (changed N/A YoY), and the FY2020 full-year result was $1.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue grew to $1.5 million in Q4 2020, from $1.3 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.5 million in Q4 2020 to a low of $1.1 million in Q4 2017.
- A 3-year average of $1.2 million and a median of $1.2 million in 2018 frame the typical range for Non-Current Deffered Revenue.
- Peak annual rise in Non-Current Deffered Revenue reached 24.44% in 2018, while the deepest fall reached 24.44% in 2018.
- Tracing CVSI's Non-Current Deffered Revenue over 3 years: stood at $1.1 million in 2017, then rose by 24.44% to $1.3 million in 2018, then advanced by 9.33% to $1.5 million in 2020.
- Business Quant data shows CVSI's Non-Current Deffered Revenue at $1.5 million in Q4 2020, $1.3 million in Q4 2018, and $1.2 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.45 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Jun 30, 2018 | 1.19 Mn |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 1.07 Mn |